Hao Feng

2.2k total citations
79 papers, 1.5k citations indexed

About

Hao Feng is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Hao Feng has authored 79 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 22 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Hao Feng's work include Immunotherapy and Immune Responses (8 papers), Chemokine receptors and signaling (7 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Hao Feng is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Chemokine receptors and signaling (7 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Hao Feng collaborates with scholars based in China, Germany and Greece. Hao Feng's co-authors include Aiguo Lu, Jingkun Zhao, Yaping Zong, Baochi Ou, Congcong Zhu, Puxiongzhi Wang, Dingpei Han, Minhua Zheng, Jing Ping Sun and Di Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Hao Feng

68 papers receiving 1.4k citations

Peers

Hao Feng
Comparison fields: 5 of 118
  • Molecular Biology 606
  • Oncology 506
  • Cancer Research 298
  • Immunology 231
  • Surgery 211
Replace Shengping Li with:
Shengping Li China
Hirohisa Ogawa Japan
Wanli Liu China
Yohei Funakoshi Japan
Jian Lei China
Christina Hackl Germany
Mohamed H. Abdel‐Rahman United States
Cuihua Lu China
Stephen G. Maher Ireland
Guanghui Li China
Shengping Li China View profile →
Citations per field, relative to Hao Feng
Hao Feng · 1×
Citations per year, relative to Hao Feng
Hao Feng · 1×

Countries citing papers authored by Hao Feng

Since Specialization
Citations

This map shows the geographic impact of Hao Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Feng more than expected).

Fields of papers citing papers by Hao Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Feng. The network helps show where Hao Feng may publish in the future.

Co-authorship network of co-authors of Hao Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Feng. A scholar is included among the top collaborators of Hao Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Feng. Hao Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 2
3 3
4 0
5 1
6 33
7 7
8 1
9 60
10 26
11 195
12
Biomarkers and long-term prognosis of colorectal schistosomiasis-associated rectosigmoid cancer: a retrospective study
1
13 16
14 10
15 30
16 64
17 29
18 2
19 12
20 24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026